嘉必优生物技术（武汉）股份有限公司 股东会议事规则 第一章 总则 第一条 为维护嘉必优生物技术（武汉）股份有限公司（以下简称"公司"）及 股东的合法权益，建立完善的公司治理结构，规范股东会的组织和行为，提高股 东会议事效率，根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华 人民共和国证券法》（以下简称"《证券法》"）《上市公司治理准则》《上市公司股 东会规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市 公司自律监管指引第 1 号——规范运作》等法律、行政法规、部门规章、规范性 文件及《嘉必优生物技术（武汉）股份有限公司章程》（以下简称"《公司章程》"） 的相关规定，结合公司实际，制定本规则。 第二条 公司应当严格按照法律、行政法规、《公司章程》以及本规则的相关 规定召开股东会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当 勤勉尽责，确保股东会正常召开和依法行使职权。 第三条 公司召开股东会，应当聘请律师对以下问题出具法律意见并公告： (一)会议的召集、召开程序是否符合法律、行政法规、《公司章程》和本规 则的规定； (二)出席会议 ...

嘉必优生物技术（武汉）股份有限公司 董事会议事规则 第一条 为进一步明确嘉必优生物技术（武汉）股份有限公司（以下简称"公 司"）董事会的职责权限，规范董事会的议事方式和决策程序，保障董事会决策 的合法化、科学化、制度化，根据《中华人民共和国公司法》（以下简称"《公 司法》"）《中华人民共和国证券法》《上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上市公 司治理准则》等法律、行政法规、部门规章及《嘉必优生物技术（武汉）股份有 限公司章程》（以下简称"《公司章程》"）的相关规定，结合公司的实际情况， 制定本规则。 第二条 公司依法设立董事会，董事会是公司经营管理的决策机构，维护公 司和全体股东的利益，在《公司法》《公司章程》和股东会赋予的职权范围内行 使决策权，对股东会负责。 第二章 董事 1 第三条 公司董事为自然人，有下列情形之一的，不能担任公司的董事： (一)无民事行为能力或者限制民事行为能力； (二)因贪污、贿赂、侵占财产、挪用财产或者破坏社会主义市场经济秩序， 被判处刑罚，或者因犯罪被剥夺政治权利，执行期满未逾五年，被宣告 缓刑的，自缓刑考验期满 ...

证券代码：688089 证券简称：嘉必优 公告编号：2025-077 嘉必优生物技术（武汉）股份有限公司 关于取消监事会、变更注册地址并修订《公司章程》及修订、 制定公司部分治理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 嘉必优生物技术（武汉）股份有限公司（以下简称"公司"）于 2025 年 10 月 27 日召开第四届董事会第十次会议，审议通过了《关于取消监事会、变更注 册地址并修订<公司章程>的议案》《关于修订及新增制定部分公司治理制度的 议案》，同日第四届监事会第十次会议审议通过了《关于取消监事会并修订<公 司章程>的议案》，现将有关情况公告如下： 一、取消监事会 根据 2024 年 7 月 1 日起实施的《中华人民共和国公司法》、中国证监会《关 于新<公司法>配套制度规则实施相关过渡期安排》《上市公司治理准则（2025 年修订）》《上市公司章程指引（2025 年修订）》等相关法律、行政法规、规 范性文件的规定，公司将不再设置监事会，由董事会审计委员会履行《公司法》 规定的监事会职权，公司《监事会议事 ...

证券代码：688089 证券简称：嘉必优 公告编号：2025-078 嘉必优生物技术（武汉）股份有限公司 关于召开2025年第二次临时股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 召开会议的基本情况 （一） 股东大会类型和届次 2025年第二次临时股东大会 召开日期时间：2025 年 11 月 18 日 14 点 00 分 召开地点：武汉市东湖新技术开发区高科园三路 89 号公司会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 11 月 18 日 重要内容提示： 至2025 年 11 月 18 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过互 股东大会召开日期：2025年11月18日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三 ...

Group 1: Storage Industry - The storage industry continues to show signs of improvement, with Samsung Electronics increasing the operational capacity of its NAND factory, achieving over 80% utilization in Q3, a 10% increase from the previous quarter [3] - Taiwan's TSMC indicated a strong demand for high-end storage driven by AI, predicting an increase in storage foundry prices in Q4, with visibility extending into the first half of next year [3] Group 2: Advanced Manufacturing - Defu Technology, a leader in lithium battery copper foil, reported a Q3 revenue of 3.201 billion yuan, a 47.88% year-on-year increase, and a net profit of 28 million yuan, up 128.27% [7] - The company plans to invest 1 billion yuan to expand its production capacity for high-frequency and high-speed copper foils, which are less correlated with the price cycles of lithium battery copper foils, thus improving profit margins [7] Group 3: Electric Vehicles - Tesla reported a record Q3 revenue of $28.1 billion, a 12% year-on-year increase, but a net profit of $1.77 billion, down 29% [8] - The decline in profit is attributed to reduced electric vehicle prices and a 50% increase in operating costs, primarily due to investments in AI and other R&D projects [8] - The fastest-growing segment for Tesla is its energy generation and storage business, which saw a 44% revenue increase to $3.42 billion in Q3 [8] Group 4: Consumer Sector - Pop Mart reported a Q3 revenue growth rate of 245%-250%, with domestic revenue increasing by 185%-190% and overseas revenue by 365%-370% [11] - The company is expected to benefit from the traditional sales peak in Q4, with new product launches aimed at boosting sales during key shopping events [11] - Jia Biyou announced a revenue of approximately 428 million yuan for the first three quarters, a 10.55% increase, with net profit growth of 75.41% driven by new product demand and improved production efficiency [12]

Core Viewpoint - The company, Jiabiyou, is experiencing significant growth in its financial performance, with a notable increase in net profit and revenue driven by strong demand for its ARA and DHA products in both domestic and international markets [1][2]. Financial Performance - For the first three quarters of 2025, Jiabiyou expects to achieve a net profit of approximately 129 million yuan, representing a 53.77% increase compared to the same period in 2024 [1][2]. - The company anticipates a revenue of about 428 million yuan for the same period, reflecting a growth of 10.55% year-on-year [2]. - The net profit attributable to the parent company for 2024 was reported at 124 million yuan, showing a year-on-year increase of 35.94% [1]. Product Performance - The increase in revenue is primarily attributed to the rising sales of ARA and DHA products, alongside improvements in production efficiency and optimization of product and customer structures [2]. - The demand for DHA products is steadily increasing due to the replacement of old national standards with new ones and the recovery of the maternal and infant consumption market driven by fertility subsidies [2]. - Jiabiyou's core products, ARA and DHA, are expected to maintain their leading positions in the market, benefiting from both domestic and international growth opportunities [2].

Core Insights - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field, which is seen as a new growth point that can drive industrial structure optimization and economic transformation [1]. Group 1: Current State and Trends - The "2025 China Synthetic Biomanufacturing Industry Development White Paper" was officially released on August 1, highlighting the current state and trends of biomanufacturing [1]. - The report analyzes the global biomanufacturing industry, including key platform facilities and a comparative study between China and the U.S. in the biomanufacturing sector [5][6]. Group 2: Policy Landscape - The report outlines major domestic and international policies affecting biomanufacturing from 2024 to 2025, providing insights into regulatory frameworks that could impact industry growth [5]. Group 3: Industry Map and Applications - A detailed analysis of the biomanufacturing industry chain and key application areas is presented, including sectors such as pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5][6]. - The report identifies ten leading companies in China's biomanufacturing industry, showcasing their roles and contributions [6]. Group 4: Company Strategies - The report includes a summary of the synthetic biology strategies of 15 listed companies, highlighting their respective directions and market positioning [6]. Group 5: Investment and Challenges - An overview of the investment and financing situation in the domestic synthetic biology sector for the period of 2024 to mid-2025 is provided, indicating the financial landscape for potential investors [6]. - The report discusses challenges faced by the biomanufacturing industry in China and offers targeted policy recommendations to address these issues [6].

Core Insights - The report from Tianfeng Securities highlights the release of the State Council's opinions on implementing "AI+" actions across six key areas by August 26, 2025, which include AI in science and technology, industrial development, consumer quality enhancement, public welfare, governance capabilities, and global cooperation [1] Group 1: Key Areas of Focus - The six key areas for accelerated implementation of "AI+" actions are: "AI+" in science and technology, "AI+" in industrial development, "AI+" in consumer quality enhancement, "AI+" in public welfare, "AI+" in governance capabilities, and "AI+" in global cooperation [1] - The report suggests focusing on companies such as Xindong Company (02400, AI+ gaming), Huashu Gaoke (688433.SH, AI+ intelligent manufacturing), Guodun Quantum (688027.SH, AI+ quantum technology), and Uxin (UXIN.US, AI+ used cars) [1] Group 2: Investment Recommendations - A total of 50 representative stocks have been selected from A-shares, Hong Kong stocks, and US-listed Chinese companies to showcase the current layout of "AI+" applications in these six key areas [1] - Key recommended stocks include: Shuanghuan Transmission (002472.SZ, AI+ industrialization/intelligent robotics), Orbbec (688322.SH, AI+ hardware), Shengye (06069, AI+ supply chain finance platform), Zhizi City Technology (09911, AI+ global social), Bairong Cloud-W (06608, AI+ financial information), and Jiabiyou (688089.SH, AI+ biomanufacturing) [1]

Group 1 - The report highlights that national top-level policies are guiding the rapid development of six key areas in "AI+ applications" as outlined in the State Council's opinion released on August 26, 2025 [2][8] - The six key areas include "AI+" in scientific technology, industrial development, consumer quality enhancement, public welfare, governance capabilities, and global cooperation [2][8] - By 2027, it is expected that AI will be widely integrated into these six areas, with the application penetration rate of new intelligent terminals exceeding 70% [9] Group 2 - The report identifies 50 representative stocks across A-shares, Hong Kong stocks, and US-listed Chinese companies that are actively engaged in "AI+ applications" within the six key areas [3] - Key recommended stocks include: - Shuanghuan Transmission (002472.SZ) for AI+ industrialization and intelligent robotics - Orbbec (688322.SH) for AI+ hardware - Shengye (6069.HK) for AI+ supply chain finance [3] - Stocks to watch include: - Xindong Company (2400.HK) for AI+ gaming - Huazhu Gaoke (688433.SH) for AI+ intelligent manufacturing - Guodun Quantum (688027.SH) for AI+ quantum technology [3] Group 3 - The report elaborates on the "AI+" scientific technology direction, which includes accelerating scientific discovery processes, driving innovation in technology research and development models, and innovating social science research methods [12][17][24] - Specific companies mentioned in the "AI+" scientific technology sector include: - iFlytek (002230.SZ) focusing on AI core technology and applications in various fields [13] - Zhongke Shuguang (603019.SH) emphasizing AI-driven digital infrastructure [13] - BGI Genomics (688114.SH) integrating AI into life sciences [13] Group 4 - The "AI+" industrial development direction aims to cultivate new intelligent native models and promote the intelligent transformation of traditional industries [28] - Companies highlighted in this sector include: - Daotong Technology (688208.SH) for AI+ automotive diagnostics [30] - Dingjie Smart (300378.SZ) for AI+ manufacturing digitalization [30] - Huichan Co., Ltd. (688500.SH) for AI+ data intelligence [30] Group 5 - The "AI+" consumer quality enhancement direction focuses on expanding service consumption scenarios and improving the quality of life services [49] - Companies in this area include: - Xindong Company (2400.HK) for AI+ gaming [51] - Giant Network (002558.SZ) integrating AI into core gaming products [51] - Perfect World (002624.SZ) utilizing AI tools in game development [51]

Market Overview - The Shanghai Composite Index closed at 3839.76 points, with a decline of 1.95% [1] - The total trading volume of A-shares reached 1,954.408 billion yuan [1] Technical Analysis - A total of 207 A-shares experienced a "death cross" where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Dashengda: -1.36% - Guanghetong: -1.33% - Songyang Resources: -1.32% [1] Individual Stock Performance - Dashengda (603687) saw a decline of 6.44% with a trading turnover of 3.58% and a latest price of 8.42 yuan, which is 9.17% below the 10-day moving average [1] - Guanghetong (300638) decreased by 5.86%, with a turnover of 5.63% and a latest price of 28.25 yuan, 8.55% below the 10-day moving average [1] - Songyang Resources (603863) dropped 10.02%, with a turnover of 8.88% and a latest price of 19.31 yuan, 14.01% below the 10-day moving average [1] Additional Notable Stocks - Other stocks with significant declines include: - Chuan Dong (603767): -9.94%, latest price 24.36 yuan, 10.84% below the 10-day moving average [1] - Lianhong (003022): -4.45%, latest price 19.56 yuan, 7.05% below the 10-day moving average [1] - Qide New Materials (300995): -6.19%, latest price 44.11 yuan, 8.55% below the 10-day moving average [1]